D.A. Davidson & Co. Alector, Inc. Transaction History
D.A. Davidson & Co.
- $11.2 Billion
- Q2 2024
Shares
3 transactions
Others Institutions Holding ALEC
# of Institutions
165Shares Held
58.1MCall Options Held
57KPut Options Held
14.9K-
Black Rock Inc. New York, NY9.1MShares$42.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$24.8 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$21.6 Million0.69% of portfolio
-
Morgan Stanley New York, NY3.01MShares$14 Million0.0% of portfolio
-
State Street Corp Boston, MA2.79MShares$13 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $386M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...